11.59 USD
↗ 0.18 (1.58%)AT CLOSE (11:59 AM EDT)
MiNK Therapeutics, Inc. Common Stock
INKTNASDAQ • USD
11.52
↘ 0.07 (0.65%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
11.52
↘ 0.07 (0.65%)
Market: OPEN
MiNK Therapeutics, Inc. Common Stock (INKT) trades at $11.52 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (81.0%) and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$11.47
High?$11.68
Low?$11.31
Prev. Close?$11.41
Volume?4.3K
Avg. Volume?12.4K
VWAP?$11.46
Rel. Volume?0.35x
Bid / Ask
Bid?$9.63 × 100
Ask?$13.95 × 100
Spread?$4.32
Midpoint?$11.79
Valuation & Ratios
Market Cap?58.2M
Shares Out?5.1M
Float?2.0M
Float %?39.2%
P/E Ratio?N/A
P/B Ratio?-4.15
EPS?-$2.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
Themes
Employees
15
Market Cap
58.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-10-15
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Phone: 212-994-8250
NEW YORK, NY 10010
Phone: 212-994-8250
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?52
Piotroski F-Score?0/9Weak
Altman Z-Score?-26.09Distress
Confidence?53%Low
Short InterestHigh
Short % of Float?3.33%Low
Short Interest?65.0K
Days to Cover?6.8
Free Float2.0M
Avg Daily Volume9.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?1.23Adequate
Quick Ratio?1.23Adequate
Cash Ratio?1.16Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-4.15CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?81.0%STRONG▾
Peers50
S&P97
ROA?-118.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-6830483
Enterprise Value?$49.4M
Fundamentals ratios updated end of day